These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 26268680

  • 1. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
    Alongi P, Picchio M, Zattoni F, Spallino M, Gianolli L, Saladini G, Evangelista L.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P, Evangelista L, Caobelli F, Spallino M, Gianolli L, Midiri M, Picchio M.
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
    Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
    Namura K, Minamimoto R, Yao M, Makiyama K, Murakami T, Sano F, Hayashi N, Tateishi U, Ishigaki H, Kishida T, Miura T, Kobayashi K, Noguchi S, Inoue T, Kubota Y, Nakaigawa N.
    BMC Cancer; 2010 Dec 03; 10():667. PubMed ID: 21129184
    [Abstract] [Full Text] [Related]

  • 10. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Park JW, Jo MK, Lee HM.
    BJU Int; 2009 Mar 03; 103(5):615-9. PubMed ID: 19007371
    [Abstract] [Full Text] [Related]

  • 11. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
    Fuccio C, Ceci F, Castellucci P, Spinapolice EG, Palumbo R, D'Ambrosio D, Bernardo A, Brunocilla E, Schiavina R, Maffione AM, Chondrogiannis S, Grassetto G, Colletti PM, Rubello D, Fanti S, Trifirò G.
    Clin Nucl Med; 2014 Jun 03; 39(6):e320-4. PubMed ID: 24566409
    [Abstract] [Full Text] [Related]

  • 12. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
    Hou G, Zhao D, Jiang Y, Zhu Z, Huo L, Li F, Cheng W.
    Cancer Imaging; 2021 Feb 25; 21(1):25. PubMed ID: 33632314
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 25; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 25; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
    Ferda J, Ferdova E, Hora M, Hes O, Finek J, Topolcan O, Kreuzberg B.
    Anticancer Res; 2013 Jun 25; 33(6):2665-72. PubMed ID: 23749925
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T, Ozülker F, Ozbek E, Ozpaçaci T.
    Nucl Med Commun; 2011 Apr 25; 32(4):265-72. PubMed ID: 21301376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.